hydroxyurea has been researched along with Anemia in 42 studies
Anemia: A reduction in the number of circulating ERYTHROCYTES or in the quantity of HEMOGLOBIN.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We present a case of oral ulceration in a patient with essential thrombocythaemia, that proved to be secondary to treatment with hydroxyurea." | 8.80 | Oral ulcers caused by hydroxyurea. ( Lindsey, L; Paleri, V, 2000) |
| "Eighty-five patients with extensive chronic plaque psoriasis, unresponsive to conventional topical therapy, were treated with long-term hydroxyurea in a dose of 0." | 7.67 | Hydroxyurea in the management of therapy resistant psoriasis. ( Cotterill, JA; Goodfield, MJ; Layton, AM; Sheehan-Dare, RA, 1989) |
| " Black pigment gallstones caused by elevated bilirubin excretion are common." | 4.86 | Gastrointestinal and hepatic complications of sickle cell disease. ( Ebert, EC; Hagspiel, KD; Nagar, M, 2010) |
| "We present a case of oral ulceration in a patient with essential thrombocythaemia, that proved to be secondary to treatment with hydroxyurea." | 4.80 | Oral ulcers caused by hydroxyurea. ( Lindsey, L; Paleri, V, 2000) |
| "Eighty-five patients with extensive chronic plaque psoriasis, unresponsive to conventional topical therapy, were treated with long-term hydroxyurea in a dose of 0." | 3.67 | Hydroxyurea in the management of therapy resistant psoriasis. ( Cotterill, JA; Goodfield, MJ; Layton, AM; Sheehan-Dare, RA, 1989) |
| "Median survival of patients with myelofibrosis with myeloid metaplasia (MMM) ranges from 3." | 2.41 | Prognostic factors and current practice in treatment of myelofibrosis with myeloid metaplasia: an update anno 2000. ( Cervantes, F, 2001) |
| "Idiopathic myelofibrosis is the least common and carries the worst prognosis of the chronic myeloproliferative disorders." | 2.40 | Pathogenesis and management of idiopathic myelofibrosis. ( Reilly, JT, 1998) |
| "Idiopathic myelofibrosis is reviewed from several aspects." | 2.38 | Idiopathic myelofibrosis: historical review, diagnosis and management. ( Weinstein, IM, 1991) |
| "The slower appearance of CFU-E in polycythemia was corrected by the injection of erythropoietin (Ep) 8 h prior to sacrifice, but an absolute increase in colony number only occurred when Ep was injected 24 h previously." | 1.27 | Studies on the kinetics of the erythroid colony-forming cell. ( Lipschitz, DA; Udupa, KB, 1986) |
| "mm." | 1.25 | Hydroxyurea in stage D carcinoma of the prostate: a pilot study. ( Cromie, W; Lerner, H; Longo, S; Malloy, T, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 21 (50.00) | 18.7374 |
| 1990's | 7 (16.67) | 18.2507 |
| 2000's | 6 (14.29) | 29.6817 |
| 2010's | 7 (16.67) | 24.3611 |
| 2020's | 1 (2.38) | 2.80 |
| Authors | Studies |
|---|---|
| Pan, DQ | 1 |
| Zhao, WS | 1 |
| Yin, CX | 1 |
| He, H | 1 |
| Lin, R | 1 |
| Zhao, K | 1 |
| Ye, JY | 1 |
| Liu, QF | 1 |
| Dai, M | 1 |
| Chang, L | 1 |
| Duan, MH | 1 |
| Park, S | 1 |
| Hamel, JF | 1 |
| Toma, A | 1 |
| Kelaidi, C | 1 |
| Thépot, S | 1 |
| Campelo, MD | 1 |
| Santini, V | 1 |
| Sekeres, MA | 1 |
| Balleari, E | 1 |
| Kaivers, J | 1 |
| Sapena, R | 1 |
| Götze, K | 1 |
| Müller-Thomas, C | 1 |
| Beyne-Rauzy, O | 1 |
| Stamatoullas, A | 1 |
| Kotsianidis, I | 1 |
| Komrokji, R | 1 |
| Steensma, DP | 1 |
| Fensterl, J | 1 |
| Roboz, GJ | 1 |
| Bernal, T | 1 |
| Ramos, F | 1 |
| Calabuig, M | 1 |
| Guerci-Bresler, A | 1 |
| Bordessoule, D | 1 |
| Cony-Makhoul, P | 1 |
| Cheze, S | 1 |
| Wattel, E | 1 |
| Rose, C | 1 |
| Vey, N | 1 |
| Gioia, D | 1 |
| Ferrero, D | 1 |
| Gaidano, G | 1 |
| Cametti, G | 1 |
| Pane, F | 1 |
| Sanna, A | 1 |
| Germing, U | 1 |
| Sanz, GF | 1 |
| Dreyfus, F | 1 |
| Fenaux, P | 1 |
| Kundu, MC | 1 |
| Gore, LR | 1 |
| Maguire, S | 1 |
| Gilmartin, AG | 1 |
| Verstovsek, S | 1 |
| Passamonti, F | 1 |
| Rambaldi, A | 1 |
| Barosi, G | 1 |
| Rosen, PJ | 1 |
| Rumi, E | 1 |
| Gattoni, E | 1 |
| Pieri, L | 1 |
| Guglielmelli, P | 1 |
| Elena, C | 1 |
| He, S | 1 |
| Contel, N | 1 |
| Mookerjee, B | 1 |
| Sandor, V | 1 |
| Cazzola, M | 1 |
| Kantarjian, HM | 1 |
| Barbui, T | 3 |
| Vannucchi, AM | 1 |
| Oberoi, S | 1 |
| Das, R | 1 |
| Trehan, A | 1 |
| Ahluwalia, J | 1 |
| Bansal, D | 1 |
| Malhotra, P | 1 |
| Marwaha, RK | 1 |
| Bandyopadhyay, D | 1 |
| Manna, S | 1 |
| Hajra, A | 1 |
| Bhattacharya, TD | 1 |
| Ebert, EC | 1 |
| Nagar, M | 1 |
| Hagspiel, KD | 1 |
| Martínez-Trillos, A | 1 |
| Gaya, A | 1 |
| Maffioli, M | 1 |
| Arellano-Rodrigo, E | 1 |
| Calvo, X | 1 |
| Díaz-Beyá, M | 1 |
| Cervantes, F | 2 |
| Finazzi, G | 2 |
| Ruggeri, M | 1 |
| Rodeghiero, F | 1 |
| DE BERGSAGEL, DE | 1 |
| FRENKEL, EP | 2 |
| ALFREY, CP | 1 |
| THURMAN, WG | 2 |
| SKINNER, WN | 1 |
| SMILEY, JD | 1 |
| WATKINS, WL | 1 |
| GRIFFITH, KM | 1 |
| SEARS, ME | 1 |
| HOWE, CD | 1 |
| SAMUELS, ML | 1 |
| La Spina, M | 1 |
| Russo, G | 1 |
| Letvin, NL | 1 |
| Linch, DC | 1 |
| Beardsley, GP | 1 |
| McIntyre, KW | 1 |
| Nathan, DG | 2 |
| Lee, EW | 1 |
| Kocsis, JJ | 1 |
| Snyder, R | 1 |
| Mayhew, CN | 1 |
| Phillips, JD | 1 |
| Greenberg, RN | 1 |
| Birch, NJ | 1 |
| Elford, HL | 1 |
| Gallicchio, VS | 1 |
| Reilly, JT | 1 |
| Hirri, HM | 1 |
| Green, PJ | 1 |
| Paleri, V | 1 |
| Lindsey, L | 1 |
| Bowers, M | 1 |
| Lerner, H | 1 |
| Malloy, T | 1 |
| Cromie, W | 1 |
| Longo, S | 1 |
| McDonagh, KT | 1 |
| Dover, GJ | 1 |
| Donahue, RE | 1 |
| Agricola, B | 1 |
| Byrne, E | 1 |
| Nienhuis, AW | 1 |
| Balducci, L | 1 |
| Hardy, CL | 1 |
| Weinstein, IM | 1 |
| Ebbe, S | 1 |
| Stamatoyannopoulos, G | 1 |
| Veith, R | 1 |
| Galanello, R | 1 |
| Papayannopoulou, T | 1 |
| Datta, MC | 1 |
| Dowla, HA | 1 |
| Spears, HJ | 1 |
| Layton, AM | 1 |
| Sheehan-Dare, RA | 1 |
| Goodfield, MJ | 1 |
| Cotterill, JA | 1 |
| Alter, BP | 2 |
| Wagner, CK | 2 |
| Susser, LS | 1 |
| Weinberg, RS | 1 |
| Udupa, KB | 1 |
| Lipschitz, DA | 1 |
| Mason, JE | 1 |
| DeVita, VT | 1 |
| Canellos, GP | 1 |
| Hodgson, GS | 1 |
| Moschella, SL | 1 |
| Greenwald, MA | 1 |
| Slack, NM | 1 |
| Jones, R | 1 |
| Yamamoto, RS | 1 |
| Weisburger, EK | 1 |
| Korzis, J | 1 |
| Card, RT | 1 |
| Lee, JD | 1 |
| McGrath, M | 1 |
| Valberg, LS | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| An Integrated European Platform to Conduct Translational Studies in Myelodysplastic Syndromes Based on the EuroBloodNet Infrastructure[NCT04174547] | 8,670 participants (Anticipated) | Observational | 2019-09-30 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
8 reviews available for hydroxyurea and Anemia
| Article | Year |
|---|---|
Gastrointestinal and hepatic complications of sickle cell disease.
Topics: Anemia; Anemia, Sickle Cell; Antisickling Agents; Bilirubin; Blood Transfusion; Gallstones; Humans; | 2010 |
New drugs for childhood anemia.
Topics: Adult; Age Factors; Anemia; Anemia, Hemolytic, Autoimmune; Anemia, Sickle Cell; Antibodies, Monoclon | 2003 |
The use of ferrokinetics in the study of experimental anemia.
Topics: Anemia; Animals; Benzene; Cytarabine; Erythropoiesis; Hematopoietic Stem Cells; Humans; Hydroxyurea; | 1981 |
Pathogenesis and management of idiopathic myelofibrosis.
Topics: Anemia; Animals; Bone Marrow; Bone Marrow Transplantation; Cladribine; Combined Modality Therapy; Di | 1998 |
Oral ulcers caused by hydroxyurea.
Topics: Aged; Anemia; Humans; Hydroxyurea; Male; Mouth Mucosa; Nucleic Acid Synthesis Inhibitors; Oral Ulcer | 2000 |
Prognostic factors and current practice in treatment of myelofibrosis with myeloid metaplasia: an update anno 2000.
Topics: Aged; Anemia; Aneuploidy; Angiogenesis Inhibitors; Bone Marrow Transplantation; Case Management; Com | 2001 |
Efficacy and safety of hydroxyurea in patients with essential thrombocythemia.
Topics: Adult; Aged; Aged, 80 and over; Anemia; Cell Transformation, Neoplastic; Cohort Studies; Female; Fol | 2001 |
Idiopathic myelofibrosis: historical review, diagnosis and management.
Topics: Anemia; Bone Marrow; Bone Marrow Transplantation; Busulfan; Combined Modality Therapy; Diagnosis, Di | 1991 |
2 trials available for hydroxyurea and Anemia
| Article | Year |
|---|---|
A phase 2 study of ruxolitinib, an oral JAK1 and JAK2 Inhibitor, in patients with advanced polycythemia vera who are refractory or intolerant to hydroxyurea.
Topics: Adult; Aged; Aged, 80 and over; Anemia; Contraindications; Drug-Related Side Effects and Adverse Rea | 2014 |
Single reversal trial of hydroxyurea (NSC-32065) in 91 patients with advanced cancer.
Topics: Anemia; Asparaginase; Azaserine; Breast Neoplasms; Clinical Trials as Topic; Colonic Neoplasms; Drug | 1970 |
32 other studies available for hydroxyurea and Anemia
| Article | Year |
|---|---|
Topics: Adult; Aged; Anemia; Bone Marrow; Female; Hemoglobins; Humans; Hydroxyurea; Male; Middle Aged; Myelo | 2022 |
Outcome of Lower-Risk Patients With Myelodysplastic Syndromes Without 5q Deletion After Failure of Erythropoiesis-Stimulating Agents.
Topics: Aged; Aged, 80 and over; Anemia; Antilymphocyte Serum; Antineoplastic Agents; Arsenic; Azacitidine; | 2017 |
Development and Characterization of a Model for Inducing Fetal Hemoglobin Production in Cynomolgus Macaques (
Topics: Anemia; Animals; Disease Models, Animal; Fetal Hemoglobin; Hydroxyurea; Macaca fascicularis; Male; P | 2018 |
HbSD-Punjab: clinical and hematological profile of a rare hemoglobinopathy.
Topics: Acute Chest Syndrome; Anemia; Antisickling Agents; Child; Child, Preschool; Chromatography, High Pre | 2014 |
Atypical CML with massive splenic infarct: an extremely rare presentation.
Topics: Abdominal Pain; Anemia; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Fatal Outcom | 2015 |
Efficacy and tolerability of hydroxyurea in the treatment of the hyperproliferative manifestations of myelofibrosis: results in 40 patients.
Topics: Adult; Aged; Aged, 80 and over; Anemia; Antisickling Agents; Bone and Bones; Female; Humans; Hydroxy | 2010 |
Efficacy and safety of long-term use of hydroxyurea in young patients with essential thrombocythemia and a high risk of thrombosis.
Topics: Adolescent; Adult; Anemia; Cohort Studies; Follow-Up Studies; Hemorrhage; Humans; Hydroxyurea; Incid | 2003 |
MEGALOBLASTIC ERYTHROPOIESIS INDUCED BY HYDROXYUREA (NSC-32065).
Topics: Anemia; Anemia, Pernicious; Animals; Antineoplastic Agents; Bone Marrow Cells; Bone Marrow Diseases; | 1964 |
STUDIES ON A METABOLIC DEFECT INDUCED BY HYDROXYUREA (NSC-32065).
Topics: Anemia; Anemia, Macrocytic; Animals; Antineoplastic Agents; Bone Marrow Cells; Cattle; Cytosine Nucl | 1964 |
STUDY OF SERUM B12 AND FOLATE IN PATIENTS TREATED WITH HYDROXYUREA (NSC-32065).
Topics: Anemia; Anemia, Macrocytic; Antineoplastic Agents; Blood Chemical Analysis; Child; Folic Acid; Human | 1964 |
HYDROXYUREA (NSC-32065): RESULTS OF A PHASE I STUDY.
Topics: Anemia; Anemia, Aplastic; Antineoplastic Agents; Drug Therapy; Hydroxyurea; Leukopenia; Statistics a | 1964 |
PHASE II STUDIES OF HYDROXYUREA (NSC-32065) IN ADULTS: CANCER OF THE BREAST.
Topics: Anemia; Anemia, Myelophthisic; Antineoplastic Agents; Breast Neoplasms; Drug Therapy; Erythema; Estr | 1964 |
PHASE II STUDIES OF HYDROXYUREA (NSC-32065) IN ADULTS: UROLOGIC AND GYNECOLOGIC NEOPLASMS.
Topics: Adenocarcinoma; Anemia; Anemia, Aplastic; Antineoplastic Agents; Carcinoma, Squamous Cell; Drug Ther | 1964 |
Augmentation of fetal-hemoglobin production in anemic monkeys by hydroxyurea.
Topics: Anemia; Animals; Azacitidine; Bloodletting; DNA; Erythrocyte Count; Fetal Hemoglobin; Globins; Hydro | 1984 |
In vivo and in vitro comparison of the short-term hematopoietic toxicity between hydroxyurea and trimidox or didox, novel ribonucleotide reductase inhibitors with potential anti-HIV-1 activity.
Topics: Acquired Immunodeficiency Syndrome; Anemia; Animals; Anti-HIV Agents; Benzamidines; Cells, Cultured; | 1999 |
Pure red cell aplasia in a patient with chronic granulocytic leukaemia treated with interferon-alpha.
Topics: Aged; Anemia; Blood Transfusion; Bone Marrow; Chromosome Deletion; Chromosomes, Human, Pair 22; Huma | 2000 |
Hydroxyurea.
Topics: Alopecia; Anemia; Bone Marrow; DNA Replication; Enzyme Inhibitors; HIV Infections; Humans; Hydroxyur | 1997 |
Hydroxyurea in stage D carcinoma of the prostate: a pilot study.
Topics: Adenocarcinoma; Aged; Anemia; Bone Neoplasms; Chlorotrianisene; Estrogens; Humans; Hydroxyurea; Leuk | 1975 |
Hydroxyurea-induced HbF production in anemic primates: augmentation by erythropoietin, hematopoietic growth factors, and sodium butyrate.
Topics: Administration, Oral; Anemia; Animals; Bloodletting; Butyrates; Butyric Acid; Cell Division; Chromat | 1992 |
High proliferation of early hemopoietic progenitors in tumor-bearing mice.
Topics: Anemia; Animals; Bone Marrow; Carcinoma; Cell Division; Hematopoiesis; Hematopoietic Cell Growth Fac | 1992 |
Megakaryocyte size and ploidy in thrombocytopenic or megakaryocytopenic mice.
Topics: Anemia; Animals; Blood Platelets; Hydroxyurea; Immune Sera; Megakaryocytes; Mice; Mice, Mutant Strai | 1990 |
Hb F production in stressed erythropoiesis: observations and kinetic models.
Topics: Anemia; Animals; Azacitidine; Cell Cycle; Cell Differentiation; Cytarabine; Erythropoiesis; Fetal He | 1985 |
Hydroxyurea-induced switching of hemoglobin proportions toward newborn values in normal adult rats is blocked by acetylsalicylic acid.
Topics: Aging; Anemia; Animals; Animals, Newborn; Aspirin; Fetal Hemoglobin; Hemoglobins; Hydroxyurea; Rats; | 1989 |
Hydroxyurea in the management of therapy resistant psoriasis.
Topics: Adult; Aged; Anemia; Female; Hemorrhagic Disorders; Humans; Hydroxyurea; Male; Middle Aged; Psoriasi | 1989 |
Modulation of mouse hemoglobin expression by hydroxyurea and erythropoietin in vivo.
Topics: Anemia; Animals; Erythrocyte Count; Erythropoietin; Female; Hemoglobins; Hydroxyurea; Mice; Mice, In | 1989 |
A murine model for hemoglobin regulation: hydroxyurea increases mouse minor hemoglobin in vivo.
Topics: Anemia; Animals; Erythrocyte Count; Gene Expression Regulation; Genes; Globins; Hemoglobin A; Hydrox | 1987 |
Studies on the kinetics of the erythroid colony-forming cell.
Topics: Anemia; Animals; Blood Sedimentation; Bone Marrow Cells; Cells, Cultured; Colony-Forming Units Assay | 1986 |
Thrombocytosis in chronic granulocytic leukemia: incidence and clinical significance.
Topics: Anemia; Azauridine; Blood Cell Count; Blood Platelets; Bone Marrow Examination; Busulfan; Cell Trans | 1974 |
Properties of haemopoietic stem cells in phenylhydrazine treated mice.
Topics: Anemia; Animals; Cell Count; Clone Cells; Dose-Response Relationship, Radiation; Erythrocyte Count; | 1973 |
Psoriasis with hydroxyurea. An 18-month study of 60 patients.
Topics: Adult; Aged; Anemia; Chemical and Drug Induced Liver Injury; Drug Resistance; Female; Humans; Hydrox | 1973 |
Chronic administration of hydroxylamine and derivatives in mice.
Topics: Anemia; Animals; Hydroxylamines; Hydroxyurea; Mammary Neoplasms, Experimental; Mice; Ossification, H | 1967 |
The effect of hydroxyurea on erythropoiesis, erythrocyte survival, and erythrokinetics in the rabbit.
Topics: Anemia; Anemia, Hemolytic; Animals; Biological Transport; Blood Volume; Chromium Isotopes; Erythrocy | 1968 |